TABLE 4.
Cumulative frequencies of all mutations among Mycobacterium tuberculosis specimens resistant or susceptible to amikacin, kanamycin, and/or capreomycin
| Gene | Mutation | INJ | No. of INJr specimens sequenced | No. of INJs specimens sequenced | No. of INJr specimens with mutation | No. of INJs specimens with mutation | Frequency of mutation among INJr specimens (%)a | Frequency of mutation among INJs specimens (%)b |
|---|---|---|---|---|---|---|---|---|
| rrs only | 1401G | AMK | 73 | 728 | 61 | 5 | 83.6 | 0.7 |
| KAN | 121 | 680 | 61 | 5 | 50.4 | 0.7 | ||
| CAP | 70 | 731 | 59 | 7 | 84.3 | 1.0 | ||
| eis only | −12C/T | AMK | 78 | 793 | 1 | 67 | 1.3 | 8.4 |
| KAN | 141 | 730 | 37 | 31 | 26.2 | 4.2 | ||
| CAP | 75 | 796 | 1 | 67 | 1.3 | 8.4 | ||
| −10G/A | AMK | 78 | 793 | 0 | 6 | 0.0 | 0.8 | |
| KAN | 141 | 730 | 5 | 1 | 3.5 | 0.1 | ||
| CAP | 75 | 796 | 0 | 6 | 0.0 | 0.8 | ||
| −14C/T | AMK | 78 | 793 | 1 | 6 | 1.3 | 0.8 | |
| KAN | 141 | 730 | 3 | 4 | 2.1 | 0.5 | ||
| CAP | 75 | 796 | 0 | 7 | 0.0 | 0.9 | ||
| −37G/T | AMK | 78 | 793 | 0 | 4 | 0.0 | 0.5 | |
| KAN | 141 | 730 | 3 | 1 | 2.1 | 0.1 | ||
| CAP | 75 | 796 | 0 | 4 | 0.0 | 0.5 | ||
| −10G/C | AMK | 78 | 793 | 0 | 3 | 0.0 | 0.4 | |
| KAN | 141 | 730 | 0 | 3 | 0.0 | 0.4 | ||
| CAP | 75 | 796 | 0 | 3 | 0.0 | 0.4 | ||
| −15C/G | AMK | 78 | 793 | 0 | 1 | 0.0 | 0.1 | |
| KAN | 141 | 730 | 1 | 0 | 0.7 | 0.0 | ||
| CAP | 75 | 796 | 0 | 1 | 0.0 | 0.1 | ||
| rrs with no mutations | Wild type | AMK | 73 | 728 | 12 | 723 | 16.4 | 99.3 |
| KAN | 121 | 680 | 60 | 675 | 49.6 | 99.3 | ||
| CAP | 70 | 731 | 11 | 724 | 15.7 | 99.0 | ||
| rrs or eis with no mutations | Wild type | AMK | 71 | 714 | 9 | 631 | 12.7 | 88.4 |
| KAN | 119 | 666 | 18 | 622 | 15.1 | 93.4 | ||
| CAP | 68 | 717 | 9 | 631 | 13.2 | 88.0 |
Frequency of mutation among injectable (INJ)-resistant (INJr) specimens was calculated as the number of injectable-resistant specimens with the mutation/number of injectable-resistant specimens sequenced.
Frequency of mutation among injectable-sensitive (INJs) specimens was calculated as the number of injectable-sensitive specimens with the mutation/number of injectable-sensitive specimens sequenced.